Viscosalactone B

N/A

Report date: 2023/01/31 14:34:04

Base Information

Drug NameViscosalactone B
Drug Alias NameN/A
ClassificationNatural product/Extract
Mechanisms of ActionLysine-specific histone demethylase 1 inhibitors
TargetsLysine-specific histone demethylase 1
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesDandong Center Hospital
China Registration ClassN/A

Develop Information

Active CompaniesDandong Center Hospital
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A